Showing results (291-300 of 330) with videos related to

Sort By:
Pageof 33
Proceedings of the National Academy of Sciences of the United States of America|March 2, 2019
COX-2 mediates tumor-stromal prolactin signaling to initiate tumorigenesisYu Zheng, Valentine Comaills, Risa Burr, et al.
Nature Communications|December 10, 2020
HIF1A signaling selectively supports proliferation of breast cancer in the brainRichard Y Ebright, Marcus A Zachariah, Douglas S Micalizzi, et al.
Nature Methods|May 19, 2015
A microfluidic device for label-free, physical capture of circulating tumor cell clustersA Fatih Sarioglu, Nicola Aceto, Nikola Kojic, et al.
Nature Communications|January 14, 2018
Engineered nanointerfaces for microfluidic isolation and molecular profiling of tumor-specific extracellular vesiclesEduardo Reátegui, Kristan E van der Vos, Charles P Lai, et al.
Cell Reports|April 22, 2014
Isolation and molecular characterization of circulating melanoma cellsXi Luo, Devarati Mitra, Ryan J Sullivan, et al.
Cancer Discovery|August 21, 2014
Brain tumor cells in circulation are enriched for mesenchymal gene expressionJames P Sullivan, Brian V Nahed, Marissa W Madden, et al.
NPJ Precision Oncology|July 26, 2019
Blood-based monitoring identifies acquired and targetable driver HER2 mutations in endocrine-resistant metastatic breast cancerArielle J Medford, Taronish D Dubash, Dejan Juric, et al.
Science (New York, N.Y.)|February 2, 2013
Circulating breast tumor cells exhibit dynamic changes in epithelial and mesenchymal compositionMin Yu, Aditya Bardia, Ben S Wittner, et al.
Breast Cancer Research and Treatment|June 15, 2023
Modeling the novel SERD elacestrant in cultured fulvestrant-refractory HR-positive breast circulating tumor cellsTaronish D Dubash, Aditya Bardia, Brian Chirn, et al.
Science (New York, N.Y.)|July 12, 2014
Cancer therapy. Ex vivo culture of circulating breast tumor cells for individualized testing of drug susceptibilityMin Yu, Aditya Bardia, Nicola Aceto, et al.
Pageof 33